Protection of mice from Mycobacterium avium infection by recombinant interleukin-12
暂无分享,去创建一个
R. Nakamura | T. Kasama | K. Soejima | M. Hosaka | T. Katsura | T. Mochizuki | K. Kobayashi | J. Yamazaki
[1] G. Trinchieri,et al. The role of interleukin 12 in the immune response, disease and therapy. , 1994, Immunology today.
[2] M. Gately,et al. Interleukin 12 at the site of disease in tuberculosis. , 1994, The Journal of clinical investigation.
[3] L. Bermudez,et al. Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. , 1994, The Journal of infectious diseases.
[4] S. Ehlers,et al. Progress in TB research: Robert Koch's dilemma revisited. , 1994, Immunology today.
[5] A. Sher,et al. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Schaub,et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.
[7] H. Maeda,et al. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis , 1993, Infection and immunity.
[8] R. Rerko,et al. Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.
[9] P. Scott. IL-12: initiation cytokine for cell-mediated immunity. , 1993, Science.
[10] A. Dannenberg. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. , 1991, Immunology today.
[11] M. Denis. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria , 1991, Clinical and experimental immunology.
[12] M. Denis. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. , 1991, Cellular immunology.
[13] L. Bermudez,et al. Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. , 1989, Journal of immunology.
[14] Kazuo Kobayashi,et al. The role monokines in granuloma formation in mice: The ability of interleukin 1 and tumor necrosis factor-α to induce lung granulomas , 1989 .
[15] C. Kirkpatrick,et al. The immunology of mycobacterial diseases. , 1986, The American review of respiratory disease.
[16] A. Zlotnik,et al. Chronic infection due to Mycobacterium intracellulare in mice: association with macrophage release of prostaglandin E2 and reversal by injection of indomethacin, muramyl dipeptide, or interferon-gamma. , 1986, Journal of immunology.
[17] T. Tokunaga,et al. Genetic control of resistance to Mycobacterium intracellulare infection in mice , 1984, Infection and immunity.
[18] P. Gangadharam,et al. An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results. , 2015, The American review of respiratory disease.
[19] S. G. Campbell,et al. Immunity to intracellular bacteria. , 1982, Veterinary immunology and immunopathology.
[20] S. Watson,et al. Immune responses to atypical mycobacterial lung infections. , 1981, Reviews of Infectious Diseases.